Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 159 entries
Sorted by: Best Match Show Resources per page
STEM UYGULAMALARINDA ÖĞRETMEN ADAYLARININ KODLAMA EĞİTİMİ HAKKINDAKİ GÖRÜŞLERİ

Research training stem

Dilber R, Erdoğan İ, Güleryüz H.
GSID: XFOY82PDnEsJ
H Güleryüz, R Dilber, İ Erdoğan - Ağrı İbrahim Çeçen Üniversitesi …, 2020 - dergipark.org.tr

… education within the scope of STEM applications. Within this … Qualitative research method was used in the study. The data … of coding within the scope of STEM applications. The collected …

Cite
Güleryüz, H., Dilber, R., & Erdoğan, İ. (2020). STEM UYGULAMALARINDA ÖĞRETMEN ADAYLARININ KODLAMA EĞİTİMİ HAKKINDAKİ GÖRÜŞLERİ. Ağrı İbrahim Çeçen Üniversitesi Sosyal Bilimler Enstitüsü Dergisi, 6(1), 71-83.
Güleryüz, Hasan, Refik Dilber, and İbrahim Erdoğan. "STEM UYGULAMALARINDA ÖĞRETMEN ADAYLARININ KODLAMA EĞİTİMİ HAKKINDAKİ GÖRÜŞLERİ." Ağrı İbrahim Çeçen Üniversitesi Sosyal Bilimler Enstitüsü Dergisi 6.1 (2020): 71-83.
Copy Download .nbib Format: MLA
Robotic coding and 3D printer with STEM activities; the effect of science teacher candidates on STEM awareness and STEM self-efficacy

STEM training programs

Dilber R, Güleryüz H.
GSID: fwo3HP5FqOgJ
H Güleryüz, R Dilber - Education and Information Technologies, 2022 - Springer

… In this study, STEM education program covering robotics … This program lasted 2 ha week for 12 weeks (total of 48 h). … provided with STEM awareness-raising trainings. According to …

Cite
Güleryüz, H., & Dilber, R. (2022). Robotic coding and 3D printer with STEM activities; the effect of science teacher candidates on STEM awareness and STEM self-efficacy. Education and Information Technologies, 1-21.
Güleryüz, Hasan, and Refik Dilber. "Robotic coding and 3D printer with STEM activities; the effect of science teacher candidates on STEM awareness and STEM self-efficacy." Education and Information Technologies (2022): 1-21.
Copy Download .nbib Format: MLA
Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.

Oncotarget

Igarashi K, Kawaguchi K, Kiyuna T, Murakami T, Miwa S, Nelson SD, Dry SM, Li Y, Singh AS, Kimura H, Hayashi K, Yamamoto N, Tsuchiya H, Eilber FC, Hoffman RM.
PMID: 29100276
Oncotarget. 2017 Mar 24;8(44):75874-75880. doi: 10.18632/oncotarget.16548. eCollection 2017 Sep 29.

Adult pleomorphic rhabdomyosarcoma (RMS) is a rare and recalcitrant, highly-malignant mesenchymal tumor in need of improved therapeutic strategies. Our laboratory pioneered the patient-derived orthotopic xenograft (PDOX) nude mouse model with the technique of surgical orthotopic implantation (SOI). We previously...

Cite
Igarashi K, Kawaguchi K, Kiyuna T, et al. Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget. 2017;8(44):75874-75880doi: 10.18632/oncotarget.16548.
Igarashi, K., Kawaguchi, K., Kiyuna, T., Murakami, T., Miwa, S., Nelson, S. D., Dry, S. M., Li, Y., Singh, A. S., Kimura, H., Hayashi, K., Yamamoto, N., Tsuchiya, H., Eilber, F. C., & Hoffman, R. M. (2017). Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget, 8(44), 75874-75880. https://doi.org/10.18632/oncotarget.16548
Igarashi, Kentaro, et al. "Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model." Oncotarget vol. 8,44 (2017): 75874-75880. doi: https://doi.org/10.18632/oncotarget.16548
Igarashi K, Kawaguchi K, Kiyuna T, Murakami T, Miwa S, Nelson SD, Dry SM, Li Y, Singh AS, Kimura H, Hayashi K, Yamamoto N, Tsuchiya H, Eilber FC, Hoffman RM. Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget. 2017 Mar 24;8(44):75874-75880. doi: 10.18632/oncotarget.16548. eCollection 2017 Sep 29. PMID: 29100276; PMCID: PMC5652670.
Copy Download .nbib Format: NLM
Strong-field excitation of helium: bound state distribution and spin effects.

Physical review letters

Zimmermann H, Buller J, Eilzer S, Eichmann U.
PMID: 25860739
Phys Rev Lett. 2015 Mar 27;114(12):123003. doi: 10.1103/PhysRevLett.114.123003. Epub 2015 Mar 24.

Using field ionization combined with the direct detection of excited neutral atoms we measured the distribution of principal quantum number n of excited He Rydberg states after strong-field excitation at laser intensities well in the tunneling regime. Our results...

Cite
Zimmermann H, Buller J, Eilzer S, et al. Strong-field excitation of helium: bound state distribution and spin effects. Phys Rev Lett. 2015;114(12):123003doi: 10.1103/PhysRevLett.114.123003.
Zimmermann, H., Buller, J., Eilzer, S., & Eichmann, U. (2015). Strong-field excitation of helium: bound state distribution and spin effects. Physical review letters, 114(12), 123003. https://doi.org/10.1103/PhysRevLett.114.123003
Zimmermann, H, et al. "Strong-field excitation of helium: bound state distribution and spin effects." Physical review letters vol. 114,12 (2015): 123003. doi: https://doi.org/10.1103/PhysRevLett.114.123003
Zimmermann H, Buller J, Eilzer S, Eichmann U. Strong-field excitation of helium: bound state distribution and spin effects. Phys Rev Lett. 2015 Mar 27;114(12):123003. doi: 10.1103/PhysRevLett.114.123003. Epub 2015 Mar 24. PMID: 25860739.
Copy Download .nbib Format: NLM
General surgery: limb salvage for soft tissue sarcoma of the extremities.

The Western journal of medicine

Giuliano AE, Eilber FR.
PMID: 18749729
West J Med. 1985 Apr;142(4):540.

No abstract available.

Cite
Giuliano AE, Eilber FR. General surgery: limb salvage for soft tissue sarcoma of the extremities. West J Med. 1985;142(4):540
Giuliano, A. E., & Eilber, F. R. (1985). General surgery: limb salvage for soft tissue sarcoma of the extremities. The Western journal of medicine, 142(4), 540.
Giuliano, A E, and Eilber, F R. "General surgery: limb salvage for soft tissue sarcoma of the extremities." The Western journal of medicine vol. 142,4 (1985): 540.
Giuliano AE, Eilber FR. General surgery: limb salvage for soft tissue sarcoma of the extremities. West J Med. 1985 Apr;142(4):540. PMID: 18749729; PMCID: PMC1306085.
Copy Download .nbib Format: NLM
Utilizing a high fundamental frequency quartz crystal resonator as a biosensor in a digital microfluidic platform.

Sensors and actuators. A, Physical

Lederer T, Stehrer BP, Bauer S, Jakoby B, Hilber W.
PMID: 22241942
Sens Actuators A Phys. 2011 Dec;172(1):161-168. doi: 10.1016/j.sna.2011.04.032.

We demonstrate the operation of a digital microfluidic lab-on-a-chip system utilizing Electro Wetting on Dielectrics (EWOD) as the actuation principle and a High Fundamental Frequency (HFF; 50 MHz) quartz crystal microbalance (QCM) resonator as a mass-sensitive sensor. In a...

Cite
Lederer T, Stehrer BP, Bauer S, et al. Utilizing a high fundamental frequency quartz crystal resonator as a biosensor in a digital microfluidic platform. Sens Actuators A Phys. 2011;172(1):161-168doi: 10.1016/j.sna.2011.04.032.
Lederer, T., Stehrer, B. P., Bauer, S., Jakoby, B., & Hilber, W. (2011). Utilizing a high fundamental frequency quartz crystal resonator as a biosensor in a digital microfluidic platform. Sensors and actuators. A, Physical, 172(1), 161-168. https://doi.org/10.1016/j.sna.2011.04.032
Lederer, Thomas, et al. "Utilizing a high fundamental frequency quartz crystal resonator as a biosensor in a digital microfluidic platform." Sensors and actuators. A, Physical vol. 172,1 (2011): 161-168. doi: https://doi.org/10.1016/j.sna.2011.04.032
Lederer T, Stehrer BP, Bauer S, Jakoby B, Hilber W. Utilizing a high fundamental frequency quartz crystal resonator as a biosensor in a digital microfluidic platform. Sens Actuators A Phys. 2011 Dec;172(1):161-168. doi: 10.1016/j.sna.2011.04.032. PMID: 22241942; PMCID: PMC3235545.
Copy Download .nbib Format: NLM
Description of Colletotrichum lupini comb. nov. in modern terms.

Mycologia

Nirenberg HI, Feiler U, Hagedorn G.
PMID: 21156502
Mycologia. 2002 Mar-Apr;94(2):307-20.

Gloeosporium lupini Bondar is transferred to Colletotrichum. The fungus is characterized morphologically and illustrated. The two varieties, Colletotrichum lupini (Bondar) Nirenberg, Feiler & Hagedorn, comb. nov. var. lupini and Colletotrichum lupini var. setosum Nirenberg, Feiler & Hagedorn var. nov....

Cite
Nirenberg HI, Feiler U, Hagedorn G. Description of Colletotrichum lupini comb. nov. in modern terms. Mycologia. 2002;94(2):307-20
Nirenberg, H. I., Feiler, U., & Hagedorn, G. (2002). Description of Colletotrichum lupini comb. nov. in modern terms. Mycologia, 94(2), 307-20.
Nirenberg, Helgard I, et al. "Description of Colletotrichum lupini comb. nov. in modern terms." Mycologia vol. 94,2 (2002): 307-20.
Nirenberg HI, Feiler U, Hagedorn G. Description of Colletotrichum lupini comb. nov. in modern terms. Mycologia. 2002 Mar-Apr;94(2):307-20. PMID: 21156502.
Copy Download .nbib Format: NLM
Steroidal alkaloids in tissue cultures and regenerated plants of Solanum dulcamara.

Plant cell reports

Emke A, Eilert U.
PMID: 24247961
Plant Cell Rep. 1986 Feb;5(1):31-4. doi: 10.1007/BF00269712.

Callus and cell suspension cultures were established with shoots of the soladulcidine variety of the bittersweet Solanum dulcamara L. Plantlets were regenerated from undifferentiated callus. From mixotrophic callus as well as mixotrophic suspension cultures soladulicidine, solasodine and the corresponding...

Cite
Emke A, Eilert U. Steroidal alkaloids in tissue cultures and regenerated plants of Solanum dulcamara. Plant Cell Rep. 1986;5(1):31-4doi: 10.1007/BF00269712.
Emke, A., & Eilert, U. (1986). Steroidal alkaloids in tissue cultures and regenerated plants of Solanum dulcamara. Plant cell reports, 5(1), 31-4. https://doi.org/10.1007/BF00269712
Emke, A, and Eilert, U. "Steroidal alkaloids in tissue cultures and regenerated plants of Solanum dulcamara." Plant cell reports vol. 5,1 (1986): 31-4. doi: https://doi.org/10.1007/BF00269712
Emke A, Eilert U. Steroidal alkaloids in tissue cultures and regenerated plants of Solanum dulcamara. Plant Cell Rep. 1986 Feb;5(1):31-4. doi: 10.1007/BF00269712. PMID: 24247961.
Copy Download .nbib Format: NLM
Lemierre's syndrome.

International journal of emergency medicine

Eilbert W, Singla N.
PMID: 24152679
Int J Emerg Med. 2013 Oct 23;6(1):40. doi: 10.1186/1865-1380-6-40.

Lemierre's syndrome is a condition characterized by thrombophlebitis of the internal jugular vein and bacteremia caused by primarily anaerobic organisms, following a recent oropharyngeal infection. This has been an uncommon illness in the era of antibiotic therapy, though it...

Cite
Eilbert W, Singla N. Lemierre's syndrome. Int J Emerg Med. 2013;6(1):40doi: 10.1186/1865-1380-6-40.
Eilbert, W., & Singla, N. (2013). Lemierre's syndrome. International journal of emergency medicine, 6(1), 40. https://doi.org/10.1186/1865-1380-6-40
Eilbert, Wesley, and Singla, Nitin. "Lemierre's syndrome." International journal of emergency medicine vol. 6,1 (2013): 40. doi: https://doi.org/10.1186/1865-1380-6-40
Eilbert W, Singla N. Lemierre's syndrome. Int J Emerg Med. 2013 Oct 23;6(1):40. doi: 10.1186/1865-1380-6-40. PMID: 24152679; PMCID: PMC4015694.
Copy Download .nbib Format: NLM
Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models.

Oncotarget

Kawaguchi K, Igarashi K, Li S, Han Q, Tan Y, Miyake K, Kiyuna T, Miyake M, Murakami T, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Eilber FC, Hoffman RM.
PMID: 29416666
Oncotarget. 2017 Dec 12;9(1):915-923. doi: 10.18632/oncotarget.23185. eCollection 2018 Jan 02.

Melanoma is a recalcitrant disease. Melanoma patients with the BRAF-V600E mutation have been treated with the drug vemurafenib (VEM) which targets this mutation. However, we previously showed that VEM is not very effective against a BRAF-V600E melanoma mutant in...

Cite
Kawaguchi K, Igarashi K, Li S, et al. Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models. Oncotarget. 2017;9(1):915-923doi: 10.18632/oncotarget.23185.
Kawaguchi, K., Igarashi, K., Li, S., Han, Q., Tan, Y., Miyake, K., Kiyuna, T., Miyake, M., Murakami, T., Chmielowski, B., Nelson, S. D., Russell, T. A., Dry, S. M., Li, Y., Unno, M., Eilber, F. C., & Hoffman, R. M. (2018). Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models. Oncotarget, 9(1), 915-923. https://doi.org/10.18632/oncotarget.23185
Kawaguchi, Kei, et al. "Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models." Oncotarget vol. 9,1 (2018): 915-923. doi: https://doi.org/10.18632/oncotarget.23185
Kawaguchi K, Igarashi K, Li S, Han Q, Tan Y, Miyake K, Kiyuna T, Miyake M, Murakami T, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Eilber FC, Hoffman RM. Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models. Oncotarget. 2017 Dec 12;9(1):915-923. doi: 10.18632/oncotarget.23185. eCollection 2018 Jan 02. PMID: 29416666; PMCID: PMC5787523.
Copy Download .nbib Format: NLM
AUTHOR REPLY.

Urology

Moradzadeh A, Jamnagerwalla J, Eilber KS, Anger JT, Lenore Ackerman A.
PMID: 30784722
Urology. 2019 Feb;124:89-90. doi: 10.1016/j.urology.2018.05.052.

No abstract available.

Cite
Moradzadeh A, Jamnagerwalla J, Eilber KS, et al. AUTHOR REPLY. Urology. 2019;124:89-90doi: 10.1016/j.urology.2018.05.052.
Moradzadeh, A., Jamnagerwalla, J., Eilber, K. S., Anger, J. T., & Lenore Ackerman, A. (2019). AUTHOR REPLY. Urology, 12489-90. https://doi.org/10.1016/j.urology.2018.05.052
Moradzadeh, Ariel, et al. "AUTHOR REPLY." Urology vol. 124 (2019): 89-90. doi: https://doi.org/10.1016/j.urology.2018.05.052
Moradzadeh A, Jamnagerwalla J, Eilber KS, Anger JT, Lenore Ackerman A. AUTHOR REPLY. Urology. 2019 Feb;124:89-90. doi: 10.1016/j.urology.2018.05.052. PMID: 30784722.
Copy Download .nbib Format: NLM
Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model.

Oncotarget

Kawaguchi K, Igarashi K, Li S, Han Q, Tan Y, Kiyuna T, Miyake K, Murakami T, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Eilber FC, Hoffman RM.
PMID: 29156737
Oncotarget. 2017 Aug 12;8(49):85516-85525. doi: 10.18632/oncotarget.20231. eCollection 2017 Oct 17.

An excessive requirement for methionine termed methionine dependence, appears to be a general metabolic defect in cancer. We have previously shown that cancer-cell growth can be selectively arrested by methionine deprivation such as with recombinant methioninase (rMETase). The present...

Cite
Kawaguchi K, Igarashi K, Li S, et al. Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget. 2017;8(49):85516-85525doi: 10.18632/oncotarget.20231.
Kawaguchi, K., Igarashi, K., Li, S., Han, Q., Tan, Y., Kiyuna, T., Miyake, K., Murakami, T., Chmielowski, B., Nelson, S. D., Russell, T. A., Dry, S. M., Li, Y., Unno, M., Eilber, F. C., & Hoffman, R. M. (2017). Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget, 8(49), 85516-85525. https://doi.org/10.18632/oncotarget.20231
Kawaguchi, Kei, et al. "Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model." Oncotarget vol. 8,49 (2017): 85516-85525. doi: https://doi.org/10.18632/oncotarget.20231
Kawaguchi K, Igarashi K, Li S, Han Q, Tan Y, Kiyuna T, Miyake K, Murakami T, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Eilber FC, Hoffman RM. Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget. 2017 Aug 12;8(49):85516-85525. doi: 10.18632/oncotarget.20231. eCollection 2017 Oct 17. PMID: 29156737; PMCID: PMC5689627.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 159 entries